| Exotic I.R.A.’s: Leaving Stocks and Bonds Behind http://www.nytimes.com/2007... Biotechnology Articles New York Times - BRIAN HARRIS makes a 30 percent annual return on his Roth individual retirement account, but his money is not invested in a soaring biotechnology stock or a hot currency fund. Instead, Mr. Harris, a music teacher from Tucson, owns about 25 marimbas ... |
| NeoStem Chief Executive Officer Robin Smith to Ring Opening Bell at ... http://www.forbes.com/busin... Biotechnology Articles Forbes - NeoStem is a biotechnology services company enhancing the delivery of adult stem cell therapeutics to health-conscious consumers. The Company is developing a nationwide network of adult stem cell collection centers, enabling people to donate and ... |
| Montco firm's big deal http://www.philly.com/inqui... Biotechnology Articles Philadelphia Inquirer - The overwhelming majority of investment dollars is still being poured into biotechnology and medical-device sectors" in the Philadelphia region, Piscopo said. Nationally, software edged narrowly ahead of life-sciences investing in the quarter. Also ... |
| Kirin Offers to Buy 50.1 Percent of Kyowa Hakko (Update2) http://www.bloomberg.com/ap... Biotechnology Articles Bloomberg - We want to speed up the research and development in making drugs based on our biotechnology,'' Yuzuru Matsuda, president of Kyowa Hakko, told reporters in Tokyo today. Matsuda will be the president of the enlarged drug business and join Kirin's board ... |
| Syngenta Starts Research Partnership in Australia for Sugarcane ... http://news.moneycentral.ms... Biotechnology Articles MSN MoneyCentral - QUT is a leading Australian university and is widely acknowledged for its research excellence in plant biotechnology. qutbluebox is the technology transfer and commercialization company for QUT. Farmacule BioIndustries is developing molecular ... |
| Tokyo shares end morning sharply lower on strong yen, Wall St's losses ... http://www.forbes.com/afxne... Biotechnology Articles Forbes - In corporate news, Japanese brewer Kirin Holdings Co Ltd said it will acquire drugmaker Kyowa Hakko Kogyo Co to boost its pharmaceutical and biotechnology businesses amid a slowdown in its core beer operations. Kyowa Hakko said it decided at an ... |
| Bioterrorism threat warning http://www.news.com.au/cour... Biotechnology Articles News.com.au - Australians are fairly aggressive in biotechnology and the biggest things they are stockpiling are post-radiation drugs," the US law firm McKenna, Long and Aldrich partner said. "They're worried about things like suitcase bombings." Read Full ... |
| Tancredo pushes for more nuclear energy R&D http://www.salon.com/news/f... Biotechnology Articles Salon - It can be R&D into biotechnology and biofuels. There are two reasons I am willing to do that: One, the national-security thing. The other is that we have OPEC, so there isn't truly a free market. You have to have some degree of government involvement ... |
| Speedel to Continue Development of Diabetes Treatment (Update1) http://www.bloomberg.com/ap... Biotechnology Articles Bloomberg - Oct. 23 (Bloomberg) -- Speedel Holding AG, the Swiss biotechnology company that developed a hypertension drug with Novartis AG, will continue work on a diabetic kidney disease treatment that triggered safety concerns in a trial last year. Another ... |
| Tech Gets the Icahn Treatment http://www.businessweek.com... Biotechnology Articles BusinessWeek - He put Biogen Idec ( BIIB ), a biotechnology outfit, in play on Oct. 12, as well. Icahn first dabbled in technology in 2003, when he took control of money-losing XO Holdings ( XOHO ), a little-known telecom company that owns a vast fiber-optic network ... |